SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARESE, Mattia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.662
EU - Europa 2.933
AS - Asia 2.157
SA - Sud America 306
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 64
OC - Oceania 3
Totale 9.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.540
FI - Finlandia 1.922
SG - Singapore 792
CN - Cina 542
IT - Italia 299
BR - Brasile 236
VN - Vietnam 235
DE - Germania 159
HK - Hong Kong 158
GB - Regno Unito 99
PL - Polonia 75
JP - Giappone 71
FR - Francia 68
ID - Indonesia 68
TR - Turchia 67
UA - Ucraina 65
CA - Canada 58
RU - Federazione Russa 47
SE - Svezia 47
BD - Bangladesh 46
IN - India 43
MX - Messico 35
AR - Argentina 27
NO - Norvegia 22
PK - Pakistan 22
IQ - Iraq 19
ES - Italia 18
NL - Olanda 18
ZA - Sudafrica 18
CZ - Repubblica Ceca 17
BE - Belgio 15
EC - Ecuador 12
IR - Iran 12
VE - Venezuela 12
KE - Kenya 11
AT - Austria 10
MY - Malesia 10
LT - Lituania 9
MA - Marocco 9
SA - Arabia Saudita 9
IE - Irlanda 8
JM - Giamaica 8
UZ - Uzbekistan 8
CL - Cile 7
CO - Colombia 7
KR - Corea 7
SV - El Salvador 7
DK - Danimarca 6
IL - Israele 6
PT - Portogallo 6
AZ - Azerbaigian 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CR - Costa Rica 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
GE - Georgia 4
JO - Giordania 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AU - Australia 3
CH - Svizzera 3
GT - Guatemala 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
BH - Bahrain 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
RO - Romania 2
SN - Senegal 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 9.120
Salva come PNG Salva come JPEG
Città #
Helsinki 1.907
Singapore 515
Ashburn 434
San Jose 275
Chandler 212
Santa Clara 205
Fairfield 196
Beijing 178
Hong Kong 150
Council Bluffs 147
Woodbridge 131
Dallas 123
Ferrara 113
New York 100
Seattle 91
Houston 82
Ho Chi Minh City 80
Los Angeles 76
Wilmington 71
Warsaw 69
Cambridge 67
Ann Arbor 64
Tokyo 61
Hanoi 57
Jakarta 57
Munich 57
Izmir 47
Princeton 46
Shanghai 44
Jacksonville 43
Nanjing 37
Milan 36
São Paulo 36
Dearborn 34
Lauterbourg 33
Bremen 22
Chicago 22
Denver 21
Orem 21
Phoenix 20
Toronto 20
Brooklyn 17
Atlanta 16
London 16
Montreal 16
Oslo 16
Boardman 15
Mexico City 15
Moscow 15
Nanchang 15
Rome 15
Poplar 14
Brno 13
Guangzhou 13
The Dalles 13
Falkenstein 12
Lahore 12
Redwood City 12
Rio de Janeiro 12
San Diego 12
Bologna 11
Boston 11
Da Nang 11
Brussels 10
Dong Ket 10
Johannesburg 10
Manchester 10
San Francisco 10
Shenyang 10
Hebei 9
Tianjin 9
Washington 9
Baghdad 8
Brasília 8
Frankfurt am Main 8
Haiphong 8
Jiaxing 8
Nairobi 8
Buffalo 7
Chennai 7
Kyiv 7
Mumbai 7
Stockholm 7
Tashkent 7
Turku 7
Zhengzhou 7
Amsterdam 6
Copenhagen 6
Fairford 6
Indore 6
Kuala Lumpur 6
Kunming 6
Nuremberg 6
Piemonte 6
Quito 6
San Salvador 6
Santiago 6
Andover 5
Belo Horizonte 5
Charlotte 5
Totale 6.574
Salva come PNG Salva come JPEG
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.070
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 330
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 316
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 264
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 255
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 252
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 233
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 223
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 220
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 218
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 210
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 204
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 201
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 197
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 196
Protein engineering and pharmacological approaches to develop novel treatment strategies for coagulation disorders 194
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 189
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 187
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 184
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 182
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 181
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 176
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 171
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 171
An advanced method for the small-scale production of high-quality minicircle DNA 171
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 171
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 169
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 166
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 165
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 164
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 157
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 152
Identification of novel mechanisms underlying functional response to drug-induced readthrough of haemophilia B nonsense mutations 148
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 141
Next generation factor VIIa with enhanced half-life 129
Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B 110
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains 110
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 103
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 102
null 93
Totale 9.275
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022256 0 0 0 4 21 22 5 12 17 31 21 123
2022/2023436 48 61 12 62 62 50 30 31 42 5 18 15
2023/2024285 10 23 16 4 17 61 15 30 6 9 12 82
2024/20251.124 36 20 97 29 130 167 20 23 178 103 181 140
2025/20265.031 299 181 229 415 460 222 374 183 2.138 329 126 75
2026/2027584 67 149 299 69 0 0 0 0 0 0 0 0
Totale 9.275